Effect of electroacupuncture on metabolic level and quality of life in patients with obese polycystic ovary syndrome: a randomized controlled trial.

If you've been diagnosed with polycystic ovary syndrome (PCOS) and are also struggling with weight, you may be wondering whether there are options beyond medication. A new clinical trial published in Frontiers in Endocrinology suggests that electroacupuncture — a form of acupuncture that uses gentle electrical stimulation through the needles — could be a meaningful part of your care plan.

Researchers enrolled 106 women aged 18–45 who had both PCOS and obesity. Half received real electroacupuncture treatments over 12 weeks, while the other half received a sham (fake) version designed to rule out placebo effects. Participants had 24 total sessions, starting with three visits per week and gradually tapering to one per week.

The results were encouraging. Women who received real electroacupuncture lost an average of 2.46 BMI points over the 12 weeks — significantly more than the sham group. They also saw meaningful reductions in waist-hip ratio and body fat. Beyond weight, the treatment improved key markers that matter deeply for PCOS: fasting blood sugar dropped, insulin resistance improved, cholesterol and triglyceride levels fell, and the hormone prolactin decreased. Perhaps most importantly, scores on a quality-of-life questionnaire specific to PCOS improved consistently throughout the study.

The good news didn't stop when treatment ended. Benefits to BMI and quality of life were still measurable 12 weeks after the final session, suggesting the effects have some staying power. No serious side effects were reported by any participant.

For women with obese PCOS, these findings suggest electroacupuncture may offer real, measurable support for both physical and hormonal health — without medication. Of course, it works best as part of a broader care plan discussed with your doctor.

If you're interested in exploring electroacupuncture, look for a licensed acupuncturist with experience treating hormonal and reproductive health conditions.

This 12-week patient- and assessor-blinded, sham-controlled RCT (n=106; mean age 27.93 ± 3.47 years) evaluated electroacupuncture (EA) in women with obese PCOS across 24 sessions with tapering frequency. The primary outcome — BMI reduction — showed a within-group mean difference of -2.46 (95% CI: -2.67 to -2.18) and a between-group difference of -1.50 vs. sham at week 12 (P<.001), sustained at 24-week follow-up (-1.58; P<.001). Secondary outcomes demonstrated significant improvements in WHR (-0.03 between groups, P<.001), body fat mass (-2.92 kg, P<.001), fasting glucose, fasting insulin, HOMA-IR, total cholesterol, LDL-C, triglycerides, and prolactin. PCOSQ scores favored EA at all timepoints. Retention was 98%. No serious adverse events occurred. Clinically, this trial provides robust evidence supporting EA as an effective non-pharmacological adjunct for metabolic, endocrine, and quality-of-life outcomes in obese PCOS patients, with durable post-treatment effects.